Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Opioids are currently ranked as third-line agents for neuropathic pain (NP) treatment. The
opioids more frequently tested for NP were tramadol, oxycodone and morphine. In the present
study test the safety and effectiveness of methadone in patients with NP who remain
symptomatic despite the use of first and second line drugs in a placebo-controlled randomized
approach.